Analysis Of Income And Expense [Abstract]

Novonesis AS - Filing #1352055

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
17,899,000,000 DKK
17,553,000,000 DKK
Material income and expense [abstract]
Research and development expense
2,017,000,000 DKK
2,001,000,000 DKK
Other operating income (expense)
171,000,000 DKK
276,000,000 DKK
Miscellaneous other comprehensive income [abstract]
Income tax relating to exchange differences on translation of foreign operations and hedges of net investments in foreign operations included in other comprehensive income [abstract]
Income tax relating to exchange differences on translation of foreign operations included in other comprehensive income
12,000,000 DKK
15,000,000 DKK
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates accounted for using equity method
18,000,000 DKK
7,000,000 DKK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
2,485,000,000 DKK
13,000,000 DKK
16,000,000 DKK
3,024,000,000 DKK
2,472,000,000 DKK
536,000,000 DKK
113,000,000 DKK
3,929,000,000 DKK
3,939,000,000 DKK
3,676,000,000 DKK
10,000,000 DKK
140,000,000 DKK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
2,472,000,000 DKK
3,929,000,000 DKK
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests
13,000,000 DKK
10,000,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.